Figure 2From: Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany One-way sensitivity analyses considering total costs (Tornado diagram). The vertical line depicts the base-case analysis with an expected value of €127. The input parameters for the low and high cost scenarios are shown in table 1. Abbreviations: nPv = negative predictive value; ABC/3TC FDC = abacavir/lamivudine fixed dose combination.Back to article page